From Single Batch to Mass Production–Automated Platform Design Concept for a Phase II Clinical Trial Tissue Engineered Cartilage Product

From Single Batch to Mass Production–Automated Platform Design Concept for a Phase II Clinical Trial Tissue Engineered Cartilage Product

Advanced Therapy Medicinal Products (ATMP) provide promising treatment options particularly for unmet clinical needs, such as progressive and chronic diseases where currently no satisfying treatment exists. Especially from the ATMP subclass of Tissue Engineered Products (TEPs), only a few have yet b...

Full description

Bibliographic Details
Main Authors: Sebastian Haeusner, Laura Herbst, Patrick Bittorf, Thomas Schwarz, Chris Henze, Marc Mauermann, Jelena Ochs, Robert Schmitt, Ulrich Blache, Anke Wixmerten, Sylvie Miot, Ivan Martin, Oliver Pullig
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Medicine
Subjects:
ATMP
tissue engineering
GMP
manufacturing
autologous
cartilage regeneration
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.712917/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.712917/full

Similar Items